Etavopivat (Synonyms: FT-4202) |
Katalog-Nr.GC64428 |
Etavopivat ist ein potenter, selektiver, oral bioverfÜgbarer Pyruvatkinase (PKR)-Aktivator fÜr rote BlutkÖrperchen (RBC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2245053-57-8
Sample solution is provided at 25 µL, 10mM.
Etavopivat is a potent, selective, orally bioavailable red blood cell (RBC) pyruvate kinase (PKR) activator. Etavopivat has potent antisickling effects[1].
[1]. Shrestha A, et al. FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice. Blood Adv. 2021 May 11;5(9):2385-2390.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *